| 11.04.2024 14:36 | OBD | Holding(s) in Company | RNS |
| 10.04.2024 16:28 | OBD | Holding(s) in Company | RNS |
| 09.04.2024 17:35 | OBD | Holding(s) in Company | RNS |
| 09.04.2024 12:42 | OBD | Holding(s) in Company | RNS |
| 09.04.2024 11:56 | OBD | Holding(s) in Company | RNS |
| 05.04.2024 16:52 | OBD | Holding(s) in Company | RNS |
| 05.04.2024 08:28 | OBD | Holding(s) in Company | RNS |
| 03.04.2024 14:31 | OBD | Oxford BioDynamics reaches "important milestone" with new laboratory | Alliance |
| 03.04.2024 12:57 | OBD | Results of GM | RNS |
| 03.04.2024 07:00 | OBD | OBD opens UK clinical testing facility | Reach |
| 27.03.2024 14:18 | OBD | Result of AGM | RNS |
| 14.03.2024 16:53 | OBD, AFC, ECR | TRADING UPDATES: FireAngel CFO resigns; ECR Minerals raises GBP585,000 | Alliance |
| 14.03.2024 07:00 | OBD | Results of Fundraising | RNS |
| 13.03.2024 20:49 | MACF, CORA, ELEG | EARNINGS AND TRADING: PensionBee nears profit; OptiBiotix Indian deal | Alliance |
| 13.03.2024 16:45 | OBD | PrimaryBid Offer | RNS |
| 13.03.2024 16:40 | OBD | Proposed Fundraising | RNS |
| 22.02.2024 14:30 | OBD | Annual Report & Accounts | RNS |
| 17.01.2024 10:50 | OBD | CORRECT: Oxford BioDynamics plunges as annual loss widens; revenue up | Alliance |
| 17.01.2024 10:43 | OBD | CORRECT: Oxford BioDynamics plunge as annual profit rises; revenue up | Alliance |
| 17.01.2024 10:35 | OBD | Oxford BioDynamics shares plunge as annual revenue widens; revenue up | Alliance |
| 17.01.2024 10:24 | FDEV, OBD, CRPR | AIM WINNERS & LOSERS: James Cropper falls on lower outlook | Alliance |
| 17.01.2024 07:00 | OBD | Preliminary Results and Notice of AGM | RNS |
| 21.12.2023 07:20 | OBD | Notice of Results | RNS |
| 13.11.2023 10:22 | OBD | Director/PDMR Shareholding | RNS |
| 08.11.2023 07:00 | OBD | OBD strengths commercial leadership | Reach |
| 07.11.2023 12:30 | OBD | Holding(s) in Company | RNS |
| 06.11.2023 17:04 | OBD | Holding(s) in Company | RNS |
| 03.11.2023 09:29 | OBD | Director/PDMR Shareholding | RNS |
| 23.10.2023 11:09 | OBD | PDMR Dealing / Grant of Share Options | RNS |
| 20.10.2023 10:32 | OBD | IN BRIEF: Oxford BioDynamics director sells over 700,000 shares | Alliance |
| 20.10.2023 09:45 | OBD | Director/PDMR Shareholding | RNS |
| 18.10.2023 10:25 | OBD | Oxford BioDynamics in deal with Bupa to expand blood test access | Alliance |
| 18.10.2023 07:00 | OBD | Bupa UK to cover EpiSwitch® CiRT for customers | RNS |
| 06.10.2023 17:44 | OBD | Director/PDMR Shareholding | RNS |
| 03.10.2023 16:37 | OBD | Holding(s) in Company | RNS |
| 03.10.2023 10:21 | OBD, AURR, RENX | AIM WINNERS & LOSERS: Safestyle plunges as seeks cash injection | Alliance |
| 03.10.2023 10:15 | OBD | Oxford BioDynamics issued insurance reimbursement code for EpiSwitch | Alliance |
| 03.10.2023 07:00 | OBD | OBD receives reimbursement code for PSE test | RNS |
| 26.09.2023 17:41 | OBD | Oxford BioDynamics soars as validates prostate test ahead of schedule | Alliance |
| 26.09.2023 07:00 | OBD | OBD launches 94% accurate PSE test in US and UK | RNS |
| 07.09.2023 10:18 | OBD | Holding(s) in Company | RNS |
| 01.09.2023 12:34 | OBD | Amendment: Director/PDMR Shareholding | RNS |
| 31.08.2023 16:02 | OBD | Holding(s) in Company | RNS |
| 25.08.2023 09:00 | OBD | Holding(s) in Company | RNS |
| 22.08.2023 15:58 | OBD | Holding(s) in Company | RNS |
| 22.08.2023 07:00 | OBD | Holding(s) in Company | RNS |
| 22.08.2023 07:00 | OBD | Holding(s) in Company | RNS |
| 18.08.2023 11:44 | OBD | Result of General Meeting | RNS |
| 11.08.2023 15:44 | PFP, OBD, MEGP | UK shareholder meetings calendar - next 7 days | Alliance |
| 08.08.2023 16:00 | OBD | Holding(s) in Company | RNS |
| 04.08.2023 15:03 | OBD | Oxford BioDynamics raises GBP540,000 in further equity raise | Alliance |
| 04.08.2023 07:00 | OBD | Results of PrimaryBid Offer | RNS |
| 02.08.2023 11:33 | OBD | IN BRIEF: Oxford BioDynamics raises GBP5.6 million through placing | Alliance |
| 02.08.2023 07:00 | OBD | Result of Placing and Subscription | RNS |
| 01.08.2023 18:16 | OBD | Oxford BioDynamics proposes GBP7 million fundraise for EpiSwitch plans | Alliance |
| 01.08.2023 16:55 | OBD | PrimaryBid Offer | RNS |
| 01.08.2023 16:54 | OBD | Proposed Fundraising | RNS |
| 30.05.2023 10:31 | OBD, MLVN, EEE | AIM WINNERS & LOSERS: Empire Metals surges on Pitfield results | Alliance |
| 30.05.2023 09:02 | OBD | Oxford BioDynamics half-year loss widens; outlook remains uncertain | Alliance |
| 30.05.2023 07:00 | OBD | Half-year Report | RNS |
| 23.05.2023 15:46 | SAL, SCT, SBDS | UK earnings, trading statements calendar - next 7 days | Alliance |
| 16.05.2023 07:00 | OBD | Notice of Interim Results and Investor Webinar | RNS |
| 15.05.2023 18:13 | OBD, TRR, GENI | TRADING UPDATES: Trident Royalties takes interest in Mexican project | Alliance |
| 15.05.2023 07:00 | OBD | CiRT expanded validation for ICI immunotherapies | RNS |
| 02.05.2023 20:16 | ZPHR, KGH, OBD | TRADING UPDATES: Knights Group buys St James Law and Baines Wilson | Alliance |
| 02.05.2023 07:00 | OBD | US PACT Award for prognosis test for IOrelated HPD | RNS |
| 18.04.2023 07:00 | OBD | Director/PDMR Shareholding | RNS |
| 05.04.2023 17:19 | OBD | IN BRIEF: Oxford BioDynamics reports record orders for blood test | Alliance |
| 05.04.2023 07:00 | OBD | Business update for PSE and CiRT tests | RNS |
| 30.03.2023 13:04 | OBD | Result of AGM | RNS |
| 23.03.2023 15:47 | POW, POLR, PINT | UK shareholder meetings calendar - next 7 days | Alliance |
| 23.03.2023 15:19 | OBD | Holding(s) in Company | RNS |
| 22.03.2023 14:22 | OBD | Holding(s) in Company | RNS |
| 15.03.2023 11:43 | OBD | AIM Rule 17 Schedule 2(g) Update | RNS |
| 03.03.2023 16:33 | OBD | Publication of FY22 Annual Report | RNS |
